The jellyfish green fluorescent protein (GFP) 
INTRODUCTION
The observation that the jellyfish green fluorescent protein (GFP) could be fused to transcription factors (10), ion-channel proteins (6) or MAP5 (7) to create functional, fluorescent proteins that could be followed in living cells has led to the creation of a wide variety of GFP-tagged proteins (1, 9) . Surprisingly, the relatively large size of GFP, in comparison with the much smaller, more commonly used epitope tags, does not appear to be a significant constraint. However, creating the fusion between the cDNAs encoding the target protein and GFP is often timeconsuming and difficult. There are currently several ways of creating fusions, including the introduction of restriction sites by site-directed or polymerase chain reaction (PCR)-mediated mutagenesis, overlap extension reactions (5) or the use of intrinsic restriction sites and commercially available GFP vectors. While these methods work well, they frequently involve time-consuming techniques, multiple subcloning steps and/or the creation of junctions that encode unwanted protein. We sought to circumvent these limitations by designing a cloning/expression vector that would incorporate a minimum of unnecessary coding sequence between the two cDNAs and that would simplify and shorten the process of creating fusion proteins.
MATERIALS AND METHODS

PCR Conditions
Costa and Weiner (2,3) created a remarkably simple way of cloning bluntend PCR products (currently sold as pCR-Script ™; Stratagene, La Jolla, CA, USA) produced by high-fidelity polymerases such as Vent or Pfu . The critical feature of their strategy is to ligate the blunt-ended PCR product into the blunt site produced by the 8-base restriction enzyme Srf I. By combining both ligase and Srf I in a single ligation reaction, it is possible to select for recombinant clones. To use this strategy to create GFP fusions, we added a Srf I site to either the 5 ′ or 3 ′ end of GFP. We positioned the Srf I site such that the cleavage occurs between codons (Figure 1) . PCR products ligated into this site are in-frame with the GFP sequence if the product begins or ends Figure 1 . Diagram of pWay2 and pWay5. In pWay2, a Srf I site was added to the 5 ′ end of the GFP coding sequence to create a vector for placing GFP at the 3 ′ end of any amplified sequence. In pWay5, the stop codon of GFP was removed, and a Srf I site was added such that GFP can be readily placed at the 5 ′ end of any coding sequence.
with the first or last base pair of a codon, respectively. To create these vectors, the sequence encoding a "humanized" S65T mutant of GFP (Reference 11; GenBank ® Accession No. U50963; commercially available as pGreen Lantern ™-1; Life Technologies, Gaithersburg, MD, USA) was amplified with either the upper primer GCCCGGGCAGCATAGCAAGGGC-GAGGAACTGTT and lower primer ATAGCGGCCGCTCACTTGTA (to produce pWay2) or the upper primer GCTAGATCTGCCACCATGAGCAA -GGGCGAGGAACT and the lower primer AAGGCCCGGGCCCGCCGC -CCTTGTACAGTTCGTCCAT (to produce pWay5). In pWay2, designed for N-terminal fusions (Figure 1) , the primers create a Srf I site at the 5 ′ end of GFP, add a glycine and a glutamine residue, and replace the start methionine with histidine. The stop codon at the 3 ′ end of GFP is retained. To create fusions with pWay2, the amplified coding region must contain the correct ATG start codon and Kozak sequence. In pWay5, designed for C-terminal fusions, the primers remove the stop codon at the 3 ′ end of GFP and add a glycine-glycine-glycine-proline linker immediately 5 ′ to the Srf I site. PCR inserts to be used with pWay5 must contain their own stop codon. TaqDNA Polymerase (Promega, Madison, WI, USA) was used for the GFP amplification (5 U Taq , 1 µ M each primer, 0.25 mM dNTPs, 2 mM Mg 2+ and manufacturer's recommended buffer). The first cycle was 180 s at 94°C, 90 s at 63°C and 90 s at 74°C, followed by 25 more cycles (60 s at 94°C, 90 s at 63°C and 90 s at 74°C) and a final 7-min step at 74°C. These PCR products were then T/A cloned with pCR ® 3.1 (Invitrogen, Carlsbad, CA, USA). The inserts were checked for orientation and sequenced. To test the resulting constructs, we amplified two different target proteins with Vent DNA polymerase and subcloned them into Srf I pre-digested pWay2 or pWay5, as described by Costa and Weiner (2). pWay2 was fused to an N-terminal fragment of the mouse NMDA Receptor 1 subunit (GenBank Accession No. D10028) created with the upper primer CGCTCGCGCAAC -CCAGAACCAG and lower primer CTTAAATCGGCCAAAGGGACTG-AA. This fragment included the first transmembrane domain of the protein. pWay5 was fused to a soluble form of human placental alkaline phosphatase (hPLAP; GenBank Accession No. M12551) created with the upper primer ATCATCCTAGTTGAAGAAGAGA A-CCC and lower primer GGCAATAGA-GAGCTTTCAACCCG. This fragment lacked both the N-terminal signal peptide and the C-terminal recognition sequence for lipid modification, thus the product encoded a soluble protein.
Protein Expression
Clones that contained an insert in the correct orientation were tested by expression in HeLa cells. Transient expression was performed by transfection of HeLa cells infected with the recombinant vaccinia virus vTF7-3 encoding the T7 DNA polymerase (4). HeLa cells were infected at a multiplicity of infection of 10-20, followed by transfection with 5 µ g of DNA using cationic liposomes as the carrier (8) . The infection and transfection were performed in Dulbecco's modified Eagle medium (DMEM). At 3 h post-transfection, the media were replaced with DMEM supplemented with 10% fetal calf serum. At 5 h post-transfection, the cells were examined with confocal microscopy.
RESULTS AND DISCUSSION
Target proteins that were amplified and cloned appropriately into either pWay2 or pWay5 produced strong fluorescent signals that localized within the cell in patterns quite unlike that produced by GFP expressed alone ( Figure  2 ). In addition to the constructs described here, we have now successfully generated six other constructs using either pWay2 or pWay5. Each construct produced a fluorescent fusion protein.
The strength of this method is that it is simple, quick, relies on DNA polymerases with high fidelity and maximizes engineering freedom. Indeed, it makes it possible to obtain intial images of how a cloned protein is used within a cell in only 2 or 3 days. Another possible strategy would be to create analogous T/A cloning vectors, but a weakness of this approach would be the error rate of the Taqenzyme. While the strategy described here can be quite useful, there are some constraints inherent in the approach: (i) the target sequence must be amplified with primers that anneal to the DNA encoding either the start or stop of translation, and such primers may not always work; (ii) the Srf I enzyme cannot be used in the ligation reaction if the target sequence includes the rare Srf I site or if the primers used to amplify the target sequence have at their 5 ′ end the 4 bases that would reconstitute the Srf I site. At the protein level, the sequence of the Srf I site does impose some constraints on the coding region; for example, using the primers described here, where the cleavage occurs between codons, a gly96BioTechniques
Vol. 25, No. 1 (1998) cine is introduced into pWay2 and a proline into pWay5; and (iii) while most GFP fusion constructs have the GFP placed at either end of the target protein, there are some instances where the best strategy is to place the GFP in the middle of the target sequence (9) . This of course requires a very different kind of cloning strategy.
INTRODUCTION
Assays for detection of reverse transcriptase (RT) activity are important tools in detection and quantitation of retroviruses. Recently developed assays for RT are based on polymerase chain reaction (PCR) assays in which an exogenous RNA template is transcribed by RT activity in the test sample, and the resulting cDNA copies are amplified by PCR. PCR products are then quantitated by Southern blot or enzyme-linked immunosorbent assay (ELISA) (6, 19, 21, 23 ). These PCR-based RT assays are approximately a millionfold more sensitive than conventional homopolymeric RT assays, and because they detect RT rather than conserved amplifiable DNA sequences, they can be used for detection of a wide range of human and animal retroviruses.
